U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H11FN2O
Molecular Weight 194.2055
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RO-5263397

SMILES

CC1=C(F)C=CC=C1[C@H]2COC(N)=N2

InChI

InChIKey=IOHOUWIYOVWGHV-SECBINFHSA-N
InChI=1S/C10H11FN2O/c1-6-7(3-2-4-8(6)11)9-5-14-10(12)13-9/h2-4,9H,5H2,1H3,(H2,12,13)/t9-/m1/s1

HIDE SMILES / InChI

Molecular Formula C10H11FN2O
Molecular Weight 194.2055
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 18:55:38 GMT 2023
Edited
by admin
on Sat Dec 16 18:55:38 GMT 2023
Record UNII
Y2P4KD8GDR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RO-5263397
Code English
2-OXAZOLAMINE, 4-(3-FLUORO-2-METHYLPHENYL)-4,5-DIHYDRO-, (4S)-
Systematic Name English
RO5263397
Code English
(4S)-4-(3-FLUORO-2-METHYLPHENYL)-4,5-DIHYDRO-2-OXAZOLAMINE
Systematic Name English
(S)-4-(3-FLUORO-2-METHYLPHENYL)-4,5-DIHYDROOXAZOL-2-AMINE
Systematic Name English
Code System Code Type Description
MANUFACTURER PRODUCT INFORMATION
RO-5263397
Created by admin on Sat Dec 16 18:55:38 GMT 2023 , Edited by admin on Sat Dec 16 18:55:38 GMT 2023
PRIMARY MedKoo CAT NO.: 522568, CAS NO.: 1357266-05-7Description: RO5263397 is a selective TAAR 1 agonist. RO5263397 was efficacious in reducing cocaine-mediated behaviors. RO5263397 dose-dependently prevented cocaine-induced lowering of ICSS thresholds. TAAR1 stimulation effectively suppresses the rewarding and reinforcing effects of cocaine in self-administration and ICSS models, supporting the candidacy of TAAR1 as a drug discovery target for cocaine addiction. (last updated: 1/6/2016).
PUBCHEM
56835991
Created by admin on Sat Dec 16 18:55:38 GMT 2023 , Edited by admin on Sat Dec 16 18:55:38 GMT 2023
PRIMARY
FDA UNII
Y2P4KD8GDR
Created by admin on Sat Dec 16 18:55:38 GMT 2023 , Edited by admin on Sat Dec 16 18:55:38 GMT 2023
PRIMARY
CAS
1357266-05-7
Created by admin on Sat Dec 16 18:55:38 GMT 2023 , Edited by admin on Sat Dec 16 18:55:38 GMT 2023
PRIMARY
SMS_ID
300000042479
Created by admin on Sat Dec 16 18:55:38 GMT 2023 , Edited by admin on Sat Dec 16 18:55:38 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY
This study examined the effects of a selective TAAR 1 agonist, RO5263397, on cocaine induced behavioral sensitization in rats, a rodent model of drug-induced behavioral plasticity. Daily treatment with 15mg/kg cocaine (i.p., 7 days) induced robust locomotor sensitization in rats. RO5263397 (1-10mg/kg, i.p.) alone did not significantly alter the locomotor activity. Acute treatment with RO5263397 (3.2 and 10mg/kg) did not significantly modify cocaine-induced hyperactivity, however, the induction of locomotor sensitization was significantly blocked after 7 days of daily RO5263397 treatment. More importantly, the expression of locomotor sensitization remained significantly attenuated when rats were re-tested 7 days after the last drug treatment. The marked attenuation of cocaine sensitization was also evidenced by the suppression of the dose-effect function (3.2-32mg/kg) of cocaine sensitization. Together, these data represent the first to report a critical modulatory role of TAAR 1 agonists in cocaine-induced behavioral plasticity, which may be indicative of its potential role for altering other long-lasting behavioral maladaptations of cocaine including drug addiction.